Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016 Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016" provides an overview of Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Dysbetalipoproteinemia (Type III Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016 Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Glucocorticoid-Induced Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Glucocorticoid-Induced Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Lipodystrophy Global Clinical Trials Review, H1, 2016 Lipodystrophy Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Lipodystrophy Global Clinical Trials Review, H1, 2016" provides an overview of Lipodystrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Lipodystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Global Clinical Trials Review, H1, 2016 Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Global Clinical Trials Review, H1, 2016" provides an overview of Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) clinical trials scenario. This report provides top line data relating to the clinical trials on Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2016 Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2016" provides an overview of Non-Proliferative Diabetic Retinopathy (NPDR) clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Proliferative Diabetic Retinopathy (NPDR). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016 Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Systemic Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2016 Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Pituitary ACTH Hypersecretion (Cushing Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Pituitary ACTH Hypersecretion (Cushing Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Global Clinical Trials Review, H1, 2016 Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Global Clinical Trials Review, H1, 2016" provides an overview of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) clinical trials scenario. This report provides top line data relating to the clinical trials on Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Global Clinical Trials Review, H1, 2016 Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Global Clinical Trials Review, H1, 2016" provides an overview of Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) clinical trials scenario. This report provides top line data relating to the clinical trials on Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2016 Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2016" provides an overview of Proliferative Diabetic Retinopathy (PDR) clinical trials scenario. This report provides top line data relating to the clinical trials on Proliferative Diabetic Retinopathy (PDR). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.